Related Experiment Videos
Simple new test for presumptive differentiation between genus Candida and genus Prototheca
Mycopathologia
|April 1, 1986
Summary
A simple new test differentiates Candida and Prototheca fungi. Candida species are resistant to Ribostamycin, while Prototheca species are inhibited, enabling clear distinction.
Area of Science:
- Mycology
- Clinical Microbiology
- Antimicrobial Susceptibility Testing
Background:
- Accurate differentiation between fungal genera is crucial for effective clinical management and treatment.
- Candida and Prototheca are medically relevant yeasts that can cause opportunistic infections.
- Distinguishing these genera can be challenging using traditional methods.
Purpose of the Study:
- To introduce and evaluate a novel, simple differential test for distinguishing between Candida and Prototheca.
- To assess the utility of Ribostamycin susceptibility as a key differentiator.
Main Methods:
- A novel differential test was developed utilizing a Ribostamycin-impregnated disc (60 mcg).
- Fifty-nine strains of Candida and seventy-eight strains of Prototheca were tested.
- Susceptibility patterns to Ribostamycin were observed and analyzed.
Main Results:
- All tested Candida strains exhibited resistance to Ribostamycin.
- All tested Prototheca strains showed inhibition when exposed to Ribostamycin.
- The Ribostamycin disc test demonstrated clear differential activity between the two genera.
Conclusions:
- The Ribostamycin disc test provides a simple, effective, and rapid method for differentiating Candida from Prototheca.
- This test can aid in the accurate identification of these fungi in clinical laboratories.
- Antimicrobial susceptibility testing can be leveraged for rapid genus-level differentiation.